New vitamin B12 therapy shows promise against deadly brain cancer
A repurposed vitamin therapy could rewrite treatment for aggressive brain cancer—early study sparks global media buzz.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A recent preclinical study suggests high-dose vitamin B12 therapy may enhance the immune system’s ability to target glioblastoma, one of the deadliest brain cancers. Researchers found the vitamin’s mechanism appears to activate immune responses against tumor cells, though human trials have not yet begun. Coverage from Gulf News, NDTV, Earth.com, The Cool Down, and ScienceDaily highlights the potential breakthrough, though details on dosage, efficacy, or trial timelines remain limited.
Watch for confirmation of the correct vitamin (B12 vs. B3) and updates on clinical trial initiation. If validated, this could accelerate research into vitamin-based immunotherapies for cancer.
Regulatory approval and large-scale testing will determine real-world impact.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (78% supported) Updated 57m ago.
Quick answers
Is vitamin B12 therapy already approved for glioblastoma?
No. The study is preclinical—no human trials or approvals have been announced.
Did the study involve vitamin B3 or B12?
Coverage from ScienceDaily and Gulf News confirms vitamin B12. Some outlets (NDTV, Earth.com) incorrectly cited B3, likely an error.
How soon could this reach patients?
Coverage does not specify a timeline. Preclinical to clinical transition typically takes years, depending on funding and regulatory review.
Coverage (5)
- This new vitamin B12 therapy shows promise against deadly brain cancer: Study Gulf News · 1d ago
- Can Vitamin B3 Help Fight This Deadly Brain Cancer? Here's What A New Study Suggests NDTV · 1d ago
- A common vitamin may help the immune system fight a deadly brain cancer Earth.com · 1d ago
- High doses of vitamin B3 could help in fight against deadly brain cancer, study finds The Cool Down · 1d ago
- New vitamin B12 therapy shows promise against deadly brain cancer ScienceDaily · 1d ago
Topics
Related trends
Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks
A high-profile cancer therapy study has been retracted by Nature Medicine, prompting discussions regarding international research credibility.
Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing
Nature Medicine has retracted a high-profile study concerning the impact of treatment timing on PD-1 lung cancer therapy outcomes.
GABA Immune Pathway Drives Female Brain Cancer Growth
New research identifies a sex-specific GABA signaling pathway that facilitates glioblastoma progression in females.
A molecule called MHC I was understood for decades as the thing that lets the immune system recognize cancer, until researchers found the immune system attacks hardest exactly when cancer switches it off
Cancer’s immune-evasion trick just got exposed—and it could rewrite treatment strategies
Jill Smokler, Founder Of Scary Mommy, Has Died
Jill Smokler, the creator of the prominent parenting brand Scary Mommy, has died at age 48 following a two-year battle with brain cancer.
A New Treatment for Gray Hair? Researchers Are Working on an Innovative Approach
Researchers are investigating immunotherapy techniques to potentially reverse gray hair following discoveries linked to cancer studies.